MedTrace Logo

Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty

NCT05227924 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 747

Last updated 2024-08-27

No results posted yet for this study

Summary

The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty using medical devices from SYMBOL range over a period of 10 years.

Conditions

  • Degenerative Hip Joint Disease
  • Post-traumatic Osteoarthritis
  • Hip Arthritis
  • Femoral Neck Fractures
  • Avascular Necrosis of the Femoral Head
  • Failure of Prosthetic Joint Implant

Interventions

DEVICE

Total hip arthroplasty (primary or revision)

Total hip arthroplasty with at least one medical device from the SYMBOL range

Sponsors & Collaborators

  • EVAMED

    collaborator OTHER

  • Dedienne Sante S.A.S.

    lead INDUSTRY

Principal Investigators

  • Thomas Rousseau · Clinique Mutualiste Catalane

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-21
Primary Completion
2034-09-30
Completion
2034-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05227924 on ClinicalTrials.gov